However, HFREP1 expression is strongly liver-dependent; patients with viral hepatitis, hepatic steatosis, or drug-induced liver injury frequently exhibit increased hepatic HFREP1 as part of generalized acute-phase or regenerative responses, which may confound its interpretation in metabolic screening [48,49]. Here, FGL1 is linked to fatty liver disease.